Salk School of Science schools and colleges. It is located on the top two floors of the P.S. 40 building on East 20th Street between 1st and 2nd avenue in Manhattan. The school was named for Jonas Salk, developer of the first polio vaccine. Dr. Salk approved the use of his name by NYU before his death in 1995. The school's nontraditional discovery-based learning methodology has been cited as resulting in improved cognitive and reasoning skills in students. Members of the New York medical community work with the school to develop curriculum, and members of the Schools of Medicine and New York University School
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS